Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2023-10-12
2025-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telehealth Virtual Reality Exergaming for Spinal Cord Injury
NCT05318079
Use of Interactive Gaming for Enhanced Function After Spinal Cord Injury
NCT01537978
Feasibility of the First Known Adaptive Intervention for People With SCI
NCT04726891
Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study
NCT03797378
Spinal Cord Injury Program in Exercise
NCT03925077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There continues to be a pressing need to make gaming controllers accessible to people who are unable to stand for long periods, cannot stand on a small platform due to poor balance or extreme obesity, or who are unable to stand and are full-time wheelchair users. The GAIMplank controller, was developed and tested for usability among people with mobility impairments. During usability testing, a sample of 21 adults were able to successfully access and play a series of standard PC video games using trunk/body movements to produce game play action. Using validated survey tools, participant usability scores and qualitative feedback indicated above average usability for the GAIMplank system. In addition, participants enjoyed the activity and reported game play as light to moderate intensity activity.
This project will examine the feasibility of an AVG intervention using the GAIMplank.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active video gaming
Participants will engage in 6 weeks of active video gaming (AVG), 2x/week
GAIMplank
The GAIMplank video game controller will be used to play active video games.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GAIMplank
The GAIMplank video game controller will be used to play active video games.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported physical disability that limits their mobility
* Communicate in English
Exclusion Criteria
* Body weight \>400 lbs
* Cognitive or linguistic problems with understanding instructions or filling in self-administered outcome measures in English as determined by a score of \<17 on the telephone-version of the Mini-Mental State Exam
* Any other conditions that would limit ability to play video games
* Cardiovascular disease event within the past 6 months
* Severe pulmonary disease or renal failure
* Currently pregnant
* Ongoing exacerbation of a health condition
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laurie A Malone, PhD
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WHARF
Homewood, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
90REGE000
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB-300009049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.